4.6 Article

Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Differing risk profiles for individual fracture sites: Evidence from the global longitudinal study of osteoporosis in women (GLOW)

Gordon FitzGerald et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2012)

Article Endocrinology & Metabolism

Risk Factors for Prediction of Inadequate Response to Antiresorptives

Adolfo Diez-Perez et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2012)

Article Endocrinology & Metabolism

Treatment failure in osteoporosis

A. Diez-Perez et al.

OSTEOPOROSIS INTERNATIONAL (2012)

Article Endocrinology & Metabolism

Effects of Antiresorptive Treatment on Nonvertebral Fracture Outcomes

Dawn C. Mackey et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2011)

Article Medicine, General & Internal

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Steven R. Cummings et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Endocrinology & Metabolism

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

F. H. Hooven et al.

OSTEOPOROSIS INTERNATIONAL (2009)

Article Endocrinology & Metabolism

Inadequate responders to osteoporosis treatment:: proposal for an operational definition

A. Diez-Perez et al.

OSTEOPOROSIS INTERNATIONAL (2008)

Article Endocrinology & Metabolism

FRAX™ and the assessment of fracture probability in men and women from the UK

J. A. Kanis et al.

OSTEOPOROSIS INTERNATIONAL (2008)

Article Medicine, General & Internal

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

Dennis M. Black et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Endocrinology & Metabolism

Fracture incidence and characterization in patients on osteoporosis treatment: The ICARO study

Silvano Adami et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2006)

Article Endocrinology & Metabolism

Risedronate prevents new vertebral fractures in postmenopausal women at high risk

NB Watts et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)

Article Geriatrics & Gerontology

Alendronate reduces the risk of multiple symptomatic fractures: Results from the fracture intervention trial

S Levis et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)

Article Endocrinology & Metabolism

Study subjects and ordinary patients

R Dowd et al.

OSTEOPOROSIS INTERNATIONAL (2000)